[EXPERIENCE WITH ETHYLENEIMINES].
D000818:Animals; D000970:Antineoplastic Agents; D001388:Aziridines; D002279:Carcinoma 256, Walker; D002286:Carcinoma, Ehrlich Tumor; D007938:Leukemia; D007945:Leukemia, Lymphoid; D007951:Leukemia, Myeloid; D008228:Lymphoma, Non-Hodgkin; D008748:Methylcholanthrene; D051379:Mice; D009369:Neoplasms; D009374:Neoplasms, Experimental; D051381:Rats; D012106:Research; D012509:Sarcoma; D012510:Sarcoma 180; D001357:Sarcoma, Avian; D012517:Sarcoma, Yoshida; D013852:Thiotepa; D014116:Toxicology
D000970:Antineoplastic Agents; D001388:Aziridines; D008748:Methylcholanthrene; D013852:Thiotepa
ANTINEOPLASTIC AGENTS; CARCINOMA 256, WALKER; CARCINOMA, EHRLICH TUMOR; EXPERIMENTAL LAB STUDY; LEUKEMIA, LYMPHOCYTIC; LEUKEMIA, MYELOCYTIC; LYMPHOSARCOMA; METHYLCHOLANTHRENE; MICE; NEOPLASMS, EXPERIMENTAL; RATS; ROUS SARCOMA; SARCOMA 180, CROCKER; SARCOMA, YOSHIDA; THIO-TEPA; TOXICOLOGIC REPORT
ERFAHRUNGEN MIT NEUREN ATHYLENIMINEN.